Dr John Barbara gave oral evidence in the Hepatitis C litigation about the medical profession's perception of Hepatitis C and HIV in the early 1990s, as well as the sensitivity of tests for HCV and HIV going to the root of the problem of pre-transfusions. Read more about Dr John Barbara gave oral evidence in the Hepatitis C litigation about the medical profession's perception of Hepatitis C and HIV in the early 1990s, as well as the sensitivity of tests for HCV and HIV going to the root of the problem of pre-transfusions.
In the National Blood Authority litigation, Dr Gunson gave evidence in relation to false positives in results and decisions made by the Department of Health and comparisons with the USA with regards to the decision to test for Hepatitis C and its accuracy (FDA decisions also). Read more about In the National Blood Authority litigation, Dr Gunson gave evidence in relation to false positives in results and decisions made by the Department of Health and comparisons with the USA with regards to the decision to test for Hepatitis C and its accuracy (FDA decisions also).
400 anti-HCV testing samples per day were being processed and the test was running "consistently with the manufacturer's expectations" but it was a "considerable drain on resources." Read more about 400 anti-HCV testing samples per day were being processed and the test was running "consistently with the manufacturer's expectations" but it was a "considerable drain on resources."
Dr Lloyd argued that although the evaluation of second-generation test kits had not yet been completed, UK screening should now start "come what may". Read more about Dr Lloyd argued that although the evaluation of second-generation test kits had not yet been completed, UK screening should now start "come what may".
Dr Gunson wrote to RTC directors in England and Wales informing them the Department of Health had agreed that routine anti-HCV testing could be put into operation, saying that he sought to ensure testing started simultaneously in all RTCs, and asking them to respond with the "earliest date that you could commence testing". Read more about Dr Gunson wrote to RTC directors in England and Wales informing them the Department of Health had agreed that routine anti-HCV testing could be put into operation, saying that he sought to ensure testing started simultaneously in all RTCs, and asking them to respond with the "earliest date that you could commence testing".
A letter from Dr Gunson to Professor Cash stated, in relation to anti-HCV testing, that for the UK it was "important that the SNBTS and the NBTS act in close collaboration since I can foresee difficulties if one of us introduced the test unilaterally". Read more about A letter from Dr Gunson to Professor Cash stated, in relation to anti-HCV testing, that for the UK it was "important that the SNBTS and the NBTS act in close collaboration since I can foresee difficulties if one of us introduced the test unilaterally".
Dr Harrison replied to Dr Allain stating that she did think there was exposure to possible litigation but at that time Brentwood RTC did not have the funding, equipment or staff training to commence anti-HCV testing immediately. Read more about Dr Harrison replied to Dr Allain stating that she did think there was exposure to possible litigation but at that time Brentwood RTC did not have the funding, equipment or staff training to commence anti-HCV testing immediately.
Professor Allain disagreed with Dr Harrison's analysis of the ethical position in respect of her refusal to participate in his proposed study to test for anti-HCV in samples from blood transfusion recipients. Professor Allain asked if Dr Harrison's ethical reasoning was true, why did she then not start screening all her donors now? He stated that if she did not, she was just as much open to litigation until 1 September 1991, whether she entered the study or not. Read more about Professor Allain disagreed with Dr Harrison's analysis of the ethical position in respect of her refusal to participate in his proposed study to test for anti-HCV in samples from blood transfusion recipients. Professor Allain asked if Dr Harrison's ethical reasoning was true, why did she then not start screening all her donors now? He stated that if she did not, she was just as much open to litigation until 1 September 1991, whether she entered the study or not.
Dr Jean Harrison, Director of the North East Thames RTC, declined to participate in Professor Allain's proposed study to test for anti-HCV in samples from blood transfusion recipients. Read more about Dr Jean Harrison, Director of the North East Thames RTC, declined to participate in Professor Allain's proposed study to test for anti-HCV in samples from blood transfusion recipients.
Dr Lloyd wrote to Dr Gunson asking "whether there was in a fact a strategy which involved delaying the introduction of tests whilst awaiting central funding for this test". Read more about Dr Lloyd wrote to Dr Gunson asking "whether there was in a fact a strategy which involved delaying the introduction of tests whilst awaiting central funding for this test".